Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/1/2002


1.		Phase II/III Randomized Pilot Study of Fluconazole as Prophylaxis for Mucositis/Thrush in Patients With Head and Neck Cancer Undergoing Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Completed				Over 21				Other				SCCC-92110 NCI-V93-0288, NCT00002533

Last Modified: 1/15/2007


2.		Phase III Randomized Study of ARA-C/DNR vs DHAD/VP-16 Induction Therapy Followed by ARA-C/DNR Consolidation Therapy in Older Patients with Previously Untreated Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				56 and over				NCI				SWOG-9333

Last Modified: 7/11/2007 First Published: 6/1/1999


3.		Phase III Randomized Study of Itraconazole Versus Fluconazole to Prevent Asgergillus Infections in Patients Undergoing Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				13 and over				NCI				FHCRC-1322.00 NCI-H99-0030, NCT00003883

Last Modified: 2/1/2001 First Published: 4/1/2000


4.		Phase III Randomized Study of FK463 Versus Fluconazole in the Prevention of Fungal Infections in Patients Undergoing Autologous or Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				6 months and over				NCI				NCI-00-C-0014 MCC-12202

Last Modified: 7/1/1994


5.		Phase III Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Fluconazole in the Early Empirical Treatment of Suspected Fungal Infections in Febrile Neutropenic Patients with Leukemia or Lymphoma (Summary Last Modified 07/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				at least 2 years				NCI				NCI-88-C-154A NCI-T88-0184N, T88-0184


6.		Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				13 and over				Pharmaceutical / Industry				P01899 NCT00044486


7.		Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				2 to 12				NCI, NHLBI				416 BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803

Last Modified: 10/1/1998 First Published: 11/1/1997


8.		Phase I Study of Voriconazole versus Fluconazole in Patients with Hematologic Malignancies, Hematologic Conditions, or Solid Tumors at Risk for Aspergillosis (Summary Last Modified 10/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Closed				18 and over				Pharmaceutical / Industry				MCV-CCHR-9603-2H PFIZER-95CK39-0673, NCI-G97-1325

Last Modified: 6/1/1997


9.		Phase I Pharmacokinetic Study of Fluconazole in Pediatric Cancer Patients (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care				Completed				5 to 15				NCI				NCI-89-C-24 NCI-T89-0047N, T89-0047

Last Modified: 7/1/1990


10.		Randomized Study of Fluconazole vs Clotrimazole Troches in the Treatment of Patients with Oropharyngeal Thrush in Association with Malignancy (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				13 and over								ICC-88N3 NCI-V89-0117

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute